Maria Esenkova

Regulatory Affairs Associate at Medochemie Ltd
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Sofia, Sofia City, Bulgaria, BG
Languages
  • English Full professional proficiency
  • German Limited working proficiency
  • Russian Limited working proficiency

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
Join now
You need to have a working account to view this content.
Join now

Credentials

  • Innovations and Entrepreneurship in Pharma-, Bio- and Cosmetic Technologies"
    Center for Applied Studies and Innovation, Sofia
    Jan, 2019
    - Nov, 2024
  • Deutsches Sparchdiplom (DSD II) - C1
    Kultusministerkonferenz
    Jan, 2015
    - Nov, 2024
  • Certificte of Advanced English - C1
    Cambridge Assessment English
    Jan, 2014
    - Nov, 2024
  • First Certificate in English
    Cambridge Assessment English
    Jan, 2013
    - Nov, 2024
  • Руский язык повседневнего общения - B1
    Pushkin State Russian Language Institute
    Jan, 2013
    - Nov, 2024

Experience

  • Medochemie Ltd
    • Cyprus
    • Pharmaceutical Manufacturing
    • 500 - 600 Employee
    • Regulatory Affairs Associate
      • Jul 2022 - Present

  • SOpharmacy
    • Pharmacist
      • Mar 2021 - Jul 2022

  • Неоспейс - аптека Есте
    • Pharmacist
      • Feb 2020 - Aug 2020

      selling medicinal products, with or without prescription (including medicines paid by NHIF); working with pharmacy software (Apteka Expert); consulting patients; selling dietary supplements, medical-grade cosmetics and medical supplies selling medicinal products, with or without prescription (including medicines paid by NHIF); working with pharmacy software (Apteka Expert); consulting patients; selling dietary supplements, medical-grade cosmetics and medical supplies

Education

  • Sofia University St. Kliment Ohridski
    Master of Pharmacy, Pharmacy
    2015 - 2020

Community

You need to have a working account to view this content. Click here to join now